Data represent participant dyads who were eligible and approached about study participation, and who agreed to take part in the study.
| Group | Value | 95% CI |
|---|---|---|
| Participants Consented | 125 |
Last reviewed · How we verify
Developing Text-based Support for Parents of Adolescents After an Emergency Department Visit
NA trial testing A-F texting component in Suicide in 240 participants. Completed in 26 September 2022.
| Lead sponsor | University of Michigan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 240 |
| Start date | 8 November 2021 |
| Primary completion | 26 September 2022 |
| Estimated completion | 26 September 2022 |
| Sites | 1 location across United States |
University of Michigan
13 and older, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Data represent participant dyads who were eligible and approached about study participation, and who agreed to take part in the study.
| Group | Value | 95% CI |
|---|---|---|
| Participants Consented | 125 |
Data was used to determine retention rate among the participant dyads. We report on follow up completion for both adolescent and caregiver members of the dyad.
| Group | Value | 95% CI |
|---|---|---|
| Control | 33 | |
| A-F Texting Component | 42 | |
| A-F Texting Plus P-F Texting Component | 38 |
| Group | Value | 95% CI |
|---|---|---|
| Control | 29 | |
| A-F Texting Component | 35 | |
| A-F Texting Plus P-F Texting Component | 27 |
Results represent parent participants who did not request stopping the intervention (i.e., did not request to stop receiving messages).
| Group | Value | 95% CI |
|---|---|---|
| A-F Texting Component | 42 | |
| A-F Texting Plus P-F Texting Component | 39 |
Measured using the Modified Client Satisfaction Questionnaire (CSQ), which was a 2-question survey. Each question had a range of 1-4. Adult participants were asked to rate both their overall satisfaction (1 meaning not satisfied to 4 meaning highly satisfied), and the likelihood that they would recommend their particular assigned intervention to a friend (1 meaning highly unlikely to 4 meaning highly likely).
| Group | Value | 95% CI |
|---|---|---|
| A-F Texting Component | 3.51 | ± 0.56 |
| A-F Texting Plus P-F Texting Component | 3.37 | ± 0.60 |
| Group | Value | 95% CI |
|---|---|---|
| A-F Texting Component | 3.56 | ± 0.55 |
| A-F Texting Plus P-F Texting Component | 3.43 | ± 0.66 |
Parent participant request to withdraw from the study. Study intention was to collect the number of and reasons for withdrawals, but the sole withdrawal did not provide a reason.
| Group | Value | 95% CI |
|---|---|---|
| Control | 0 | |
| A-F Texting Component | 0 | |
| A-F Texting Plus P-F Texting Component | 1 |
Time frame: Up to 12 weeks. Reporting threshold: 5%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
| Reaction | System | Control | A-F Texting Component | A-F Texting Plus P-F Texti… |
|---|---|---|---|---|
| Suicide attempt | Psychiatric disorders | — | — | — |
Most-reported serious reactions: Suicide attempt.
Data from ClinicalTrials.gov NCT05058664 adverse events section.
The researchers seek to develop a text message intervention for caregivers of adolescents at elevated suicide risk following discharge from emergency department (ED) care.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05058664.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing